Steno was in that period owned by Novo Nordisk A/S, but was on 1 January 2017 transferred to the Capital Region to become part of a new visionary centre, Steno Diabetes Center Copenhagen (SDCC).
The ambition of SDCC is to improve the entire field within diabetes in the Capital Region, but also to contribute with inspiration and new knowledge nationally and internationally. This will be done by providing the best treatment and prevention for all people with diabetes in the region.
SDCC is largest diabetes clinic in Scandinavia and treat each year more than 11,000 children and adults with diabetes from the Capital Region.
SDCC has been established by a donation of DKK 2.95 billion from the Novo Nordisk Foundation, in addition to the many joint activities in the region, this donation also made it possible to build a new diabetes centre in Herlev.
The organizational structure of SDCC generally consists of four departments and three staff functions:
- The Department of Patient Care
- The Department of Clinical and Translational Research
- The Department of Prevention, Health Promotion and Community Care
- The Department of Education
The center was established as Steno Memorial Hospital by Hans Christian Hagedorn in 1932.
His vision was to improve the treatment of diabetes and research in the disease.